While the observation of PD-L1 in glomerular compartment implies a local disturbance of peripheral tolerance, similar to that encountered in TIN, it seems that in immunotherapy-induced glomerulopathies, a systemic disruption of immune tolerance networks takes place [30,31]. The gene discussed is CD274; the disease is lipoprotein glomerulopathy.